KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Receivables (2020 - 2025)

AbCellera Biologics' Change in Receivables history spans 6 years, with the latest figure at $39.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 90.14% year-over-year to $39.7 million, compared with a TTM value of $55.6 million through Dec 2025, down 25.95%, and an annual FY2025 reading of $55.6 million, down 25.95% over the prior year.
  • Change in Receivables for Q4 2025 was $39.7 million at AbCellera Biologics, up from $3.4 million in the prior quarter.
  • The five-year high for Change in Receivables was $39.7 million in Q4 2025, with the low at -$7.9 million in Q1 2023.
  • Average Change in Receivables over 5 years is $11.8 million, with a median of $10.8 million recorded in 2023.
  • Biggest YoY gain for Change in Receivables was 1900.0% in 2023; the steepest drop was 190.45% in 2023.
  • Tracing ABCL's Change in Receivables over 5 years: stood at $3.1 million in 2021, then soared by 522.83% to $19.0 million in 2022, then crashed by 45.18% to $10.4 million in 2023, then skyrocketed by 99.86% to $20.9 million in 2024, then surged by 90.14% to $39.7 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Change in Receivables are $39.7 million (Q4 2025), $3.4 million (Q3 2025), and $11.4 million (Q2 2025).